Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) FCF Margin: 2017-2025

Historic FCF Margin for Assembly Biosciences (ASMB) over the last 6 years, with Sep 2025 value amounting to -140.65%.

  • Assembly Biosciences' FCF Margin rose 8205.00% to -140.65% in Q3 2025 from the same period last year, while for Sep 2025 it was -149.98%, marking a year-over-year decrease of 23061.00%. This contributed to the annual value of -179.33% for FY2024, which is 49328.00% down from last year.
  • Latest data reveals that Assembly Biosciences reported FCF Margin of -140.65% as of Q3 2025, which was up 19.21% from -174.09% recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' FCF Margin ranged from a high of 1,027.17% in Q4 2023 and a low of -317.68% during Q1 2024.
  • Moreover, its 3-year median value for FCF Margin was -187.34% (2024), whereas its average is -35.37%.
  • Per our database at Business Quant, Assembly Biosciences' FCF Margin crashed by 103,270bps in 2024 and then surged by 8,205bps in 2025.
  • Over the past 4 years, Assembly Biosciences' FCF Margin (Quarterly) stood at -301.92% in 2021, then reached 1,027.17% in 2023, then tumbled by 103,270bps to -5.53% in 2024, then skyrocketed by 8,205bps to -140.65% in 2025.
  • Its FCF Margin was -140.65% in Q3 2025, compared to -174.09% in Q2 2025 and -248.85% in Q1 2025.